Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · IEX Real-Time Price · USD
23.66
+0.67 (2.91%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Fulgent Genetics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
| Revenue | 287.53 | 289.21 | 618.97 | 992.58 | 421.71 | 32.53 | Upgrade
|
| Revenue Growth (YoY) | -21.20% | -53.27% | -37.64% | 135.37% | 1196.46% | 52.35% | Upgrade
|
| Cost of Revenue | 179.78 | 184.76 | 252.07 | 215.53 | 89.81 | 14.11 | Upgrade
|
| Gross Profit | 107.75 | 104.46 | 366.9 | 777.05 | 331.91 | 18.42 | Upgrade
|
| Selling, General & Admin | 126.46 | 127.87 | 143.79 | 75.17 | 30.17 | 12.31 | Upgrade
|
| Research & Development | 43.09 | 41.44 | 28.91 | 24.22 | 11.58 | 6.54 | Upgrade
|
| Depreciation & Amortization | 7.87 | 7.85 | 6.5 | 1.71 | - | - | Upgrade
|
| Operating Expenses | 177.42 | 177.15 | 179.2 | 101.1 | 41.75 | 18.85 | Upgrade
|
| Operating Income | -69.67 | -72.7 | 187.7 | 675.95 | 290.16 | -0.43 | Upgrade
|
| Interest Expense | -0.04 | -0.04 | -0.3 | -0.18 | - | - | Upgrade
|
| Interest & Investment Income | 24.74 | 20.89 | 5.11 | 0.34 | 1.44 | 0.84 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -0.49 | -0.78 | Upgrade
|
| EBT Excluding Unusual Items | -44.96 | -51.84 | 192.51 | 676.11 | 291.11 | -0.37 | Upgrade
|
| Merger & Restructuring Charges | - | - | -9.18 | - | - | - | Upgrade
|
| Impairment of Goodwill | -120.23 | -120.23 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.59 | 0.59 | 0.69 | 4.92 | -4.26 | - | Upgrade
|
| Other Unusual Items | -2.6 | -2.6 | - | - | - | - | Upgrade
|
| Pretax Income | -167.21 | -174.09 | 184.03 | 681.03 | 286.84 | -0.37 | Upgrade
|
| Income Tax Expense | 6.03 | 1.15 | 42.1 | 174.8 | 72.53 | 0.04 | Upgrade
|
| Earnings From Continuing Operations | -173.24 | -175.24 | 141.92 | 506.24 | 214.31 | -0.41 | Upgrade
|
| Net Income to Company | -173.24 | -175.24 | 141.92 | 506.24 | 214.31 | -0.41 | Upgrade
|
| Minority Interest in Earnings | 7.29 | 7.41 | 1.48 | 1.13 | - | - | Upgrade
|
| Net Income | -165.95 | -167.83 | 143.4 | 507.36 | 214.31 | -0.41 | Upgrade
|
| Net Income to Common | -165.95 | -167.83 | 143.4 | 507.36 | 214.31 | -0.41 | Upgrade
|
| Net Income Growth | - | - | -71.74% | 136.74% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 30 | 30 | 30 | 29 | 23 | 19 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 30 | 31 | 31 | 24 | 19 | Upgrade
|
| Shares Change (YoY) | -0.27% | -3.81% | -0.04% | 28.77% | 28.58% | 4.07% | Upgrade
|
| EPS (Basic) | -5.56 | -5.63 | 4.76 | 17.25 | 9.44 | -0.02 | Upgrade
|
| EPS (Diluted) | -5.56 | -5.63 | 4.63 | 16.38 | 8.91 | -0.02 | Upgrade
|
| EPS Growth | - | - | -71.73% | 83.84% | - | - | Upgrade
|
| Free Cash Flow | 17.95 | 4.8 | 234.75 | 514.77 | 105.5 | 4.34 | Upgrade
|
| Free Cash Flow Per Share | 0.60 | 0.16 | 7.58 | 16.62 | 4.39 | 0.23 | Upgrade
|
| Gross Margin | 37.47% | 36.12% | 59.28% | 78.29% | 78.70% | 56.63% | Upgrade
|
| Operating Margin | -24.23% | -25.14% | 30.32% | 68.10% | 68.80% | -1.32% | Upgrade
|
| Profit Margin | -57.71% | -58.03% | 23.17% | 51.12% | 50.82% | -1.26% | Upgrade
|
| Free Cash Flow Margin | 6.24% | 1.66% | 37.93% | 51.86% | 25.02% | 13.33% | Upgrade
|
| EBITDA | -43.74 | -46.55 | 220.36 | 686.96 | 293.12 | 1.68 | Upgrade
|
| EBITDA Margin | -15.21% | -16.10% | 35.60% | 69.21% | 69.51% | 5.16% | Upgrade
|
| D&A For EBITDA | 25.93 | 26.14 | 32.66 | 11 | 2.96 | 2.11 | Upgrade
|
| EBIT | -69.67 | -72.7 | 187.7 | 675.95 | 290.16 | -0.43 | Upgrade
|
| EBIT Margin | -24.23% | -25.14% | 30.32% | 68.10% | 68.80% | -1.32% | Upgrade
|
| Effective Tax Rate | - | - | 22.88% | 25.67% | 25.29% | - | Upgrade
|
Source: S&P Capital IQ. Standard template.